Boston Scientific (BSX) Price to Sales (2009 - 2026)

Boston Scientific has disclosed Price to Sales across 18 years of filings, most recently posting 11.37 for Q2 2026.

• In Q2 2026, Price to Sales fell 63.86% year-over-year to 11.37; the TTM figure through Jun 2026 stood at 2.95 (down 65.77% YoY), while the FY2025 annual figure was 7.05, down 10.45% from the prior year.
• Price to Sales came in at 11.37 for Q2 2026 at Boston Scientific, down from 17.93 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 32.01 in Q1 2025 to a low of 11.37 in Q2 2026.
• Average Price to Sales over 5 years is 23.51, with a median of 22.39 recorded in 2023.
• Year-over-year, Price to Sales soared 33.8% in 2024 and tumbled 63.86% in 2026.
• Over 5 years, Price to Sales stood at 20.48 in 2022, then advanced by 11.19% to 22.77 in 2023, then increased by 26.93% to 28.9 in 2024, then decreased by 7.38% to 26.77 in 2025, then plunged by 57.54% to 11.37 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 11.37 in Q2 2026, 17.93 in Q1 2026, and 26.77 in Q4 2025.